Effects of moxibustion on reproduction and metabolism of polycystic ovary syndrome: a protocol for meta-analysis and systematic review

被引:3
|
作者
Xu, Kou [1 ]
Wang, Jiajie [2 ]
Hu, Feng [2 ]
Lv, Siying [1 ]
Zhang, Yanji [1 ]
Yang, Qiqi [1 ]
Huang, Wei [2 ]
Zhou, Zhongyu [2 ,3 ]
机构
[1] Hubei Univ Chinese Med, Coll Acupuncture & Orthoped, Wuhan, Peoples R China
[2] Hubei Prov Hosp Tradit Chinese Med, Dept Acupuncture, Wuhan, Peoples R China
[3] Evidence Based Med Ctr Tradit Chinese Med China, Project Team Acupuncture & Moxibust Treatment Dom, Wuhan, Peoples R China
来源
BMJ OPEN | 2021年 / 11卷 / 08期
基金
中国国家自然科学基金;
关键词
complementary medicine; general endocrinology; subfertility; reproductive medicine; INFERTILITY; PREVALENCE; ENDOCRINE; METFORMIN; CRITERIA; WOMEN; BIAS;
D O I
10.1136/bmjopen-2021-049039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathy in women of reproductive age. Recently, moxibustion, as a complementary and alternative therapy, has been commonly used in assisted reproduction and improvement of metabolic abnormalities in patients with PCOS. Currently, intervention efficacy of the use of moxibustion in PCOS treatment still remains controversial due to lack of high-quality evidence. Consequently, this study protocol was designed to objectively review and evaluate the effectiveness and safety of moxibustion treatment for PCOS. Methods and analysis Electronic searches will be carried out from inception to May 2021 in the online databases of The Cochrane Library, PubMed, EMBASE, Chinese Biomedical Literature, Chongqing VIP Chinese Science and Technology Periodical Database (VIP) and China National Knowledge Infrastructure. The Chinese Clinical Trial Registry Center and Clinical Trials will be used for searching ongoing trials. Randomised controlled trials and the first period in randomised cross-over trials involving any type of moxibustion for patients with PCOS will be included. Primary outcomes will be the ovulation rate, pregnancy rate and sex hormone levels, and secondary outcomes will be changes in clinical symptoms and metabolic indicators, total effective rate and the incidences of side effects and adverse events. Briefly, two reviewers will independently conduct study selection and data extraction, and the risk of bias will be assessed. Prior to the formal meta-analysis, the heterogeneity of included studies will be assessed. Review Manager Statistical Software (RevMan) V.5.3 will be used for data processing. Finally, the Grading of Recommendations Assessment, Development and Evaluation method will be applied to evaluate the quality of evidence. Ethics and dissemination Ethical approval is not necessary since this study is designed as a systematic review. This study will be disseminated by a peer-review journal or conference presentation.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression
    Lim, S. S.
    Kakoly, N. S.
    Tan, J. W. J.
    Fitzgerald, G.
    Khomami, M. Bahri
    Joham, A. E.
    Cooray, S. D.
    Misso, M. L.
    Norman, R. J.
    Harrison, C. L.
    Ranasinha, S.
    Teede, H. J.
    Moran, L. J.
    OBESITY REVIEWS, 2019, 20 (02) : 339 - 352
  • [42] Acupuncture and Moxibustion for restless legs syndrome A systematic review and meta-analysis protocol
    Huang, Zhijun
    Qingqing, Cao
    Wenchun, Zhang
    Zhouhang, Wu
    Jiankun, Ren
    MEDICINE, 2020, 99 (04)
  • [43] Effects of cinnamon on controlling metabolic parameters of polycystic ovary syndrome: A systematic review and meta-analysis
    Heydarpour, Fatemeh
    Hemati, Niloofar
    Hadi, Amir
    Moradi, Sajjad
    Mohammadi, Elham
    Farzaei, Mohammad Hosein
    JOURNAL OF ETHNOPHARMACOLOGY, 2020, 254
  • [44] Effects of different insulin sensitisers in the management of polycystic ovary syndrome: A systematic review and meta-analysis
    Melin, Johanna M.
    Forslund, Maria
    Alesi, Simon J.
    Piltonen, Terhi
    Romualdi, Daniela
    Spritzer, Poli M.
    Tay, Chau Thien
    Pena, Alexia S.
    Witchel, Selma F.
    Mousa, Aya
    Teede, Helena J.
    CLINICAL ENDOCRINOLOGY, 2024, 100 (02) : 149 - 163
  • [45] Effects of atorvastatin on the insulin resistance in women of polycystic ovary syndrome A systematic review and meta-analysis
    Chen, Lin-Lin
    Zheng, Jian-Hong
    MEDICINE, 2021, 100 (24) : E26289
  • [46] The prevalence of metabolic syndrome in patients with polycystic ovary syndrome: A systematic review and meta-analysis
    Khorshidi, Ali
    Azami, Milad
    Tardeh, Samira
    Tardeh, Zeinab
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (04) : 2747 - 2753
  • [47] The association between metabolic syndrome and polycystic ovary syndrome: A systematic review and meta-analysis
    Otaghi, Masoumeh
    Azami, Milad
    Khorshidi, Ali
    Borji, Milad
    Tardeh, Zainab
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (02) : 1481 - 1489
  • [48] SEXUAL FUNCTIONINWOMENWITH POLYCYSTIC OVARY SYNDROME: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS
    Pastoor, Hester
    Bolt, Hanneke
    Burgert, Tania
    Tay, Jillian
    Mousa, Aya
    Teede, Helena
    JOURNAL OF SEXUAL MEDICINE, 2023, 20
  • [49] The role of Kisspeptin levels in polycystic ovary syndrome: a systematic review and meta-analysis
    de Assis Rodrigues, Nicole Paloma
    Lagana, Antonio Simone
    Zaia, Victor
    Vitagliano, Amerigo
    Barbosa, Caio Parente
    de Oliveira, Renato
    Trevisan, Camila Martins
    Montagna, Erik
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2019, 300 (05) : 1423 - 1434
  • [50] The mental health of women with polycystic ovary syndrome: a systematic review and meta-analysis
    Xican Yin
    Yinan Ji
    Cecilia Lai Wan Chan
    Celia Hoi Yan Chan
    Archives of Women's Mental Health, 2021, 24 : 11 - 27